SGMO
Sangamo Therapeutics, Inc.NASDAQHealthcare$0.30-7.16%ClosedMarket Cap: $111.5M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
5
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 03 | Dubois-Stringfellow Nathalie | officer: SVP-CHIEF DEVELOPMENT OFFICER | Sell | 800,000 | $0.26 | 800,000 |
| Fri Apr 03 | Jain Nikunj | officer: Principal Accounting Officer | Sell | 225,000 | $0.26 | 225,000 |
| Fri Apr 03 | Davis Gregory D | officer: Head of Research & Technology | Sell | 225,000 | $0.26 | 225,000 |
| Fri Apr 03 | Macrae Sandy | director, officer: PRESIDENT, CEO AND DIRECTOR | Sell | 2,500,000 | $0.26 | 2,500,000 |
| Fri Apr 03 | Willoughby Scott B. | officer: SVP, CHIEF LEGAL OFFICER, SECY | Sell | 800,000 | $0.26 | 800,000 |
| Thu Feb 26 | Willoughby Scott B. | officer: SVP, CHIEF LEGAL OFFICER, SECY | Sell | 12,354 | $0.47 | 651,406 |
| Thu Feb 26 | Jain Nikunj | officer: Principal Accounting Officer | Sell | 666 | $0.47 | 242,330 |
| Thu Feb 26 | Dubois-Stringfellow Nathalie | officer: SVP-CHIEF DEVELOPMENT OFFICER | Sell | 2,063 | $0.47 | 691,065 |
| Thu Feb 26 | Davis Gregory D | officer: Head of Research & Technology | Sell | 832 | $0.47 | 190,230 |
| Thu Feb 26 | Davis Gregory D | officer: Head of Research & Technology | Sell | 5,119 | $0.47 | 185,111 |
| Thu Feb 26 | Jain Nikunj | officer: Principal Accounting Officer | Sell | 5,119 | $0.47 | 237,211 |
| Thu Feb 26 | Dubois-Stringfellow Nathalie | officer: SVP-CHIEF DEVELOPMENT OFFICER | Sell | 12,354 | $0.47 | 678,711 |
| Thu Feb 26 | Macrae Sandy | director, officer: PRESIDENT, CEO AND DIRECTOR | Sell | 5,291 | $0.47 | 1,941,293 |
| Thu Feb 26 | Macrae Sandy | director, officer: PRESIDENT, CEO AND DIRECTOR | Sell | 33,637 | $0.47 | 1,907,656 |
| Thu Feb 26 | Willoughby Scott B. | officer: SVP, CHIEF LEGAL OFFICER, SECY | Sell | 1,650 | $0.47 | 663,760 |